MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Coping styles and their influence on outcomes in Parkinson’s disease

K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell (Vancovuer, BC, Canada)

Meeting: 2016 International Congress

Abstract Number: 1493

Keywords: Depression, Interventions, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Psychiatric manifestations

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To understand the associations between coping styles and various clinical symptoms and outcomes in patients with Parkinson’s disease (PD).

Background: The diagnosis of a chronic progressive neurodegenerative disorder such as Parkinson’s disease is life-altering and presents those affected with a realm of psychological and physical stressors. Research suggests that the coping style employed by patients can either facilitate or impede long-term emotional and physical well-being. In patients with PD, associations between coping style and health-related quality of life have been found, however, little is known about how these coping styles may be associated with specific disease symptoms and progression, and health behaviours.

Methods: We conducted a cross-sectional study of 75 patients with PD and 28 of their caregivers. Information was collected on demographics, coping style (Coping Inventory for Stressful Situations), psychological and cognitive functioning (Beck Depression Inventory, Starkstein Apathy Scale and Montreal Cognitive Assessment), health behaviours (Exercise Level Screen Tool), and PD symptom severity (Hoehn and Yahr scale). Patient medical records were accessed to obtain PD symptom scores and information on disease progression.

Results: The mean age of the PD subjects was 67.4 (SD 8.18) and the mean disease duration was 10.6 years (SD 6.29). Results indicate that a higher tendency to use emotion-oriented coping strategies was associated with increased depression and apathy, faster disease progression, decreased participation in physical exercise, and increased caregiver depression. No relationship was observed between cognitive functioning and coping style. No gender differences were observed.

Conclusions: Emotion-oriented coping styles appear to be maladaptive in the context of PD with respect to psychological functioning, disease progression, health behaviours, and caregiver well-being. Therapeutic interventions should be designed to reduce the amount of emotion-oriented coping that individuals with PD engage in.

To cite this abstract in AMA style:

K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell. Coping styles and their influence on outcomes in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/coping-styles-and-their-influence-on-outcomes-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/coping-styles-and-their-influence-on-outcomes-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley